Literature DB >> 10235617

Levels of hepatic stimulator substance in liver regenerating process of partially hepatectomized rats pretreated with a single dose of carbon tetrachloride.

A A Liakos1, M G Mykoniatis, M E Kokala, D G Papadimitriou, G D Liatsos.   

Abstract

Liver regeneration after injury with carbon tetrachloride (CCl4) followed by partial hepatectomy is a complex model involving toxicological, inflammatory, and necrotic processes. In the present study, the time-course of hepatic regenerative process was investigated in relation to hepatic stimulator substance (HSS) activity, administration of a single dose of CCl4 and partial (70%) hepatectomy in male rats. To evaluate liver injury events, the levels of serum aspartic aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were measured. Hepatic DNA synthesis reached a maximum at 36 hr after hepatectomy in contrast to the reported 24-hr and 32-hr peaks observed in nontreated hepatectomized rats. On the other hand, HSS activity appeared to peak at 28, 40, and 44 hr after hepatectomy in CCl4-treated rats, and it was quite a lot lower at 24, 32, 36, 48, and 60 hr. The hypothesis that HSS promotes liver regeneration but it does not initiate it, as other factors have been found to do, is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235617     DOI: 10.1023/a:1026685319823

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Effect of subtotal pancreatectomy on the rate of liver regeneration: the role of hepatic stimulator substance.

Authors:  K G Kyprianidis; M G Mykoniatis; D G Papadimitriou; A Valsamidou
Journal:  J Surg Res       Date:  1996-05       Impact factor: 2.192

2.  Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats.

Authors:  H Masunaga; N Fujise; A Shiota; Y Yamashita; H Yasuda; K Higashio
Journal:  J Pharm Pharmacol       Date:  1996-08       Impact factor: 3.765

3.  Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure.

Authors:  A Francavilla; A Azzarone; G Carrieri; U Cillo; D Van Thiel; V Subbottin; T E Starzl
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

4.  Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.

Authors:  D R LaBrecque; L A Pesch
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

5.  Possible mechanism of adenosine protection in carbon tetrachloride acute hepatotoxicity. Role of adenosine by-products and glutathione peroxidase.

Authors:  V Chagoya de Sánchez; R Hernández-Muñoz; L Yáñez; S Vidrio; M Díaz-Muñoz
Journal:  J Biochem Toxicol       Date:  1995-02

6.  The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine.

Authors:  A Francavilla; A DiLeo; L Polimeno; J Gavaler; R Pellicci; S Todo; I Kam; J Prelich; L Makowka; T E Starzl
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

7.  Hepatic stimulator substance administration enhances regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats.

Authors:  S E Theocharis; A P Margeli; C Spiliopoulou; S Skaltsas; C Kittas; A Koutselinis
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

8.  Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

Authors:  K Miyazawa; T Shimomura; N Kitamura
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

9.  Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor.

Authors:  E M Webber; M J FitzGerald; P I Brown; M H Bartlett; N Fausto
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425

10.  Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver.

Authors:  J Terblanche; K A Porter; T E Starzl; J Moore; L Patzelt; N Hayashida
Journal:  Surg Gynecol Obstet       Date:  1980-10
View more
  7 in total

1.  Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy.

Authors:  Alexandra P Margeli; Evangelos Manolis; Spyridon N Skaltsas; Kyriakos S Tsarpalis; Michael G Mykoniatis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Effect of heat and pH denaturation on the structure and conformation of recombinant human hepatic stimulator substance.

Authors:  Zhi-cheng Yang; Lin Yang; Ying-xia Zhang; He-fen Yu; Wei An
Journal:  Protein J       Date:  2007-08       Impact factor: 2.371

3.  Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat.

Authors:  Georgios Gribilas; Apostolos Zarros; Athina Zira; Costas Giaginis; Gerasimos Tsourouflis; Charis Liapi; Chara Spiliopoulou; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

4.  Platelet-activating factor inactivator (rPAF-AH) enhances liver's recovery after paracetamol intoxication.

Authors:  A D Grypioti; G Kostopanagiotou; M Mykoniatis
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

5.  Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS.

Authors:  George D Liatsos; Michael G Mykoniatis; Alexandra Margeli; Aristotelis A Liakos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

6.  Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury. importance of controlling the receptor of PAF.

Authors:  Agni D Grypioti; Georgia Kostopanagiotou; Constantinos A Demopoulos; Anastasios Roussos; Michael Mykoniatis
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

7.  Recombinant platelet-activating factor-acetylhydrolase attenuates paracetamol-induced liver oxidative stress, injury, and regeneration.

Authors:  A D Grypioti; M Mykoniatis; C A Demopoulos; G Kostopanagiotou
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.